Mon, April 18, 2022
Sun, April 17, 2022
Thu, April 14, 2022
Wed, April 13, 2022
Tue, April 12, 2022
Mon, April 11, 2022
Sun, April 10, 2022
Fri, April 8, 2022

Brian Abrahams Maintained (BCRX) at Hold with Decreased Target to $14 on, Apr 12th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-14-on-apr-12th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Abrahams of RBC Capital, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Hold with Decreased Target from $16 to $14 on, Apr 12th, 2022.

Brian has made no other calls on BCRX in the last 4 months.



There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 1 agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $14 on, Monday, April 11th, 2022


This is the rating of the analyst that currently disagrees with Brian


  • Justin Kim of "Oppenheimer" Maintained at Buy with Decreased Target to $16 on, Monday, April 11th, 2022

Publication Contributing Sources